Clinical Trial Update: A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating INCA036873 in participants with advanced solid tumors and hematologic malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• INCA036873

Snippet

Sponsor: Incyte Corporation | Conditions: Solid Tumors, Hematologic Malignancies | Phase 1 | Status: RECRUITING